Table 4.
Proportion of all identified SARS-CoV-2 respiratory viral co-infections (N = 2392).
| Respiratory Viral Pathogen Type | Identified Number (%) |
|---|---|
| EBV | 644 (26.9) |
| HHV6 | 574 (24) |
| Influenza A virus | 355 (14.8) |
| HMPV | 328 (13.7) |
| Adenovirus | 144 (6) |
| Influenza B virus | 68 (2.8) |
| Rhinovirus/Enterovirus | 68 (2.8) |
| RSV | 52 (2.2) |
| Parainfluenza [1, 2, 3 and 4] virus | 29 (1.2) |
| HcoV-OC43 | 11 (0.5) |
| Rhinovirus | 22 (0.9) |
| Influenza virus (H1N1) | 18 (0.8) |
| HcoV-HKU1 | 16 (0.7) |
| HcoV-NL63 | 13 (0.5) |
| Bocavirus | 10 (0.4) |
| HSV | 10 (0.4) |
| HcoV-229E | 9 (0.4) |
| CMV | 8 (0.3) |
| MERS-CoV | 8 (0.3) |
| Enterovirus | 1 (0.04) |
| Rotavirus | 1 (0.04) |
| Coxsackie virus | 1 (0.04) |
| Human Coronavirus 229E | 1 (0.04) |
| Herpes virus 5 | 1 (0.04) |
Abbreviations: SARS-CoV-2, severe acute respiratory syndrome coronavirus 2; RSV, respiratory syncytial virus; EBV, Epstein–Barr virus; HcoV-HKU1, human coronavirus HKU1; CMV, cytomegalovirus; HSV, herpes simplex virus; HHV6, human herpes virus 6; HMPV, human metapneumovirus.